Byrne Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.4K | Sell |
|
|||||
|
2025
Q2 | $14.2K | Hold |
|
|||||
|
2025
Q1 | $17.1K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $43.1K | Hold |
|
|||||
|
2024
Q2 | $43.1K | Hold |
|
|||||
|
2024
Q1 | $39.5K | Hold |
|
|||||
|
2023
Q4 | $35.8K | Hold |
|
|||||
|
2023
Q3 | $34K | Hold |
|
|||||
|
2023
Q2 | $29K | Hold |
|
|||||
|
2023
Q1 | $34K | Hold |
|
|||||
|
2022
Q4 | $29.6K | Sell |
|
|||||
|
2022
Q3 | $33K | Hold |
|
|||||
|
2022
Q2 | $28K | Hold |
|
|||||
|
2022
Q1 | $34K | Sell |
|
|||||
|
2021
Q4 | $34K | Buy |
|